Scientists find new protein which may reduce inflammation due to Covid-19

When the two peptides are combined, they work together to penetrate a cell's membrane and dampen an acute inflammatory response, said the researchers

Scientists have discovered a new drug which they claim could be useful in combatting inflammation of all varieties, an advance that may help in fighting aggravated immune response in respiratory illnesses such as Covid-19.

The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring small proteins, or peptides.

According to the researchers, including those from the University of Toronto in Canada, when the two peptides are combined, they work together to penetrate a cell's membrane in order to dampen an acute inflammatory response.

In the current study, they said